ResMed (RMD) Misses Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $194.78 +1.24%
EPS Growth %: +13.3%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +13.3%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.60, $0.07 worse than the analyst estimate of $1.67. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.14 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
- Schwab's May activity shows margin loans nearly double
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
